CHARTIER-KASTLER E.
- Country
- France
- Department
- Service d’Urologie
Research Overview
Data & Insights
Has run more than one trial at 0 of 8 partner sites.
Specializations
Urologic Oncology
The investigator concentrates on malignant diseases of the urinary tract, emphasizing therapeutic strategies for prostate cancer and bladder cancer across localized and metastatic stages.
- Prostate cancer
- Bladder cancer
- Renal cell carcinoma
- Upper tract urothelial carcinoma
- Metastatic disease management
Clinical focus includes integration of systemic therapies with surgical and radiotherapeutic options.
Kidney Disease and Transplantation
Research addresses progressive renal impairment, with particular attention to chronic kidney disease, kidney transplantation outcomes, and immune‑mediated graft complications.
- Chronic kidney disease
- Kidney transplantation
- APOL1-associated kidney disease
- Glomerulonephritis
- Acute kidney injury
Efforts target optimizing graft survival and mitigating proteinuric renal pathologies.
Hereditary Amyloidosis
Specialized investigations involve transthyretin‑related protein deposition disorders, including hereditary transthyretin amyloidosis with neuropathic and cardiac manifestations.
- Transthyretin amyloidosis
- Cardiac amyloidosis
- Polyneuropathy
- Hereditary amyloidosis
- Cardiomyopathy
Collaboration with cardiology and neurology enhances multidisciplinary care pathways.
Autoimmune and Inflammatory Renal Disorders
The investigator explores immune‑driven conditions that affect renal function, such as ANCA-associated vasculitis and systemic autoimmune diseases.
- ANCA-associated vasculitis
- Systemic lupus erythematosus
- Primary Sjögren's syndrome
- Immune‑mediated nephritis
- Inflammatory uropathy
Therapeutic approaches integrate targeted immunomodulation and organ‑preserving strategies.
Metabolic and Endocrine Renal Complications
Investigations address the impact of systemic metabolic disorders on kidney health, focusing on diabetes mellitus, hypertension, and obesity‑related nephropathy.
- Diabetes mellitus
- Hypertension
- Obesity
- Metabolic syndrome
- Diabetic nephropathy
Preventive and therapeutic modalities aim to reduce progression to end‑stage renal disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.